Navigation Links
Puma Biotechnology Announces Licensing Agreement with Pfizer for the Development and Commercialization of Neratinib, an Investigational Pan-HER Inhibitor; Closes $55 Million Private Placement and Completes Merger
Date:10/5/2011

LOS ANGELES, Oct. 5, 2011 /PRNewswire/ -- Puma Biotechnology, Inc., a development stage biopharmaceutical company, today announced an agreement with Pfizer to license the worldwide commercial rights to neratinib, a potent, irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, ErbB1 (EGFR), ErbB2 (HER2) and ErbB4 (HER4) kinases.  Neratinib is being studied in the neoadjuvant, adjuvant and metastatic settings in patients with HER2/ErbB2 positive breast cancer.

Under the terms of the agreement, Puma will assume sole responsibility of global product development and commercialization of neratinib.  Pfizer will be entitled to receive payments upon Puma's achievement of certain development milestones of neratinib, as well as royalty payments for any sales of neratinib.

Puma intends to focus the development of neratinib on the treatment of patients with HER2-positive locally advanced or metastatic breast cancer who have received prior trastuzumab-based therapy.  Neratinib has previously been tested in numerous clinical trials both as single agent and in combination with other anticancer drugs in this patient population.  In these studies, neratinib demonstrated substantial clinical activity and was well tolerated.  Based on the results of these studies, Puma intends to initiate clinical trials in this patient population in the first half of 2012.

Prior to the licensing agreement with Puma, Pfizer had been sponsoring two clinical trials of neratinib: 1) the NEfERTT trial, a Phase II randomized trial of neratinib in combination with paclitaxel versus trastuzumab in combination with paclitaxel for the treatment of patients who have not received previous treatment for HER2-positive metastatic breast cancer, and 2) the ExteNET trial, a Phase III study investigating the effects of neratinib after adjuvant trastuzumab in patients with early stage breast cancer.  Co
'/>"/>

SOURCE Puma Biotechnology, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Lixte Biotechnology Holdings, Inc. Announces Completion of Private Placement
4. Lixte Biotechnology Holdings Announces That Anti-Cancer Activity Against Glioblastoma in an Animal Model Was Reported at the Annual Meeting of the American Association of Cancer Research
5. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
6. Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D
7. Champions Biotechnology Begins Preclinical Development of Its Lead Oncology Drug Candidate
8. Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
9. Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30
10. Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC
11. Lixte Biotechnology Holdings Announces That Novel Compounds Being Developed as Potential Treatments for Brain Tumors Have Positive Activity in a Mouse Model of Human Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... Aug. 22, 2014 MC Medical, a subsidiary of ... Columbus, OH medical device company, have ... laparoscopic and robotic visualization system in Japan ... sale in Japan in the latter ... and an extensive product portfolio in endoscopic surgery market in ...
(Date:8/22/2014)... , Aug. 22, 2014 Research and ... "Global and Chinese Particulate Respirators Industry Report 2014" ... and Chinese Particulate Respirators Industry Report 2014 is a ... the global particulate respirators industry with a focus on ... overview of the industry including definitions, classifications, applications and ...
(Date:8/22/2014)... --  - MediaLINC unlocks the ... announced general availability of MediaLINC - its ... of education, entertainment and clinical content direct to standard ... " Lincor has already been ... to bedside smart devices, " comments Dan Byrne ...
Breaking Medicine Technology:MC Medical agrees to be the exclusive distributor of FloShield products in Japan 2Global and Chinese Particulate Respirators Industry Report 2014 2Lincor Unveils Next Generation TV-based Patient Engagement Solution 2
... Associated Microbial Genomes to Understand and Improve Plant ... and Disease Control SolutionsJatropha Genome Represents Second Milestone ... Genome Sequence in 2008LA JOLLA, Calif. and KUALA ... (SGI), a privately held company applying genomic-driven commercial ...
... Results of collaborative study could lead to development of ... high-risk diseaseMEMPHIS, Tenn., May 19 A research team ... identify cases of childhood acute lymphoblastic leukemia (ALL) that ... finding suggests specific drugs that could treat this high-risk ...
Cached Medicine Technology:First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology 2First Jatropha Genome Completed by Synthetic Genomics Inc. and Asiatic Centre for Genome Technology 3Mutant Genes in High-Risk Childhood Leukemias Identified 2Mutant Genes in High-Risk Childhood Leukemias Identified 3Mutant Genes in High-Risk Childhood Leukemias Identified 4Mutant Genes in High-Risk Childhood Leukemias Identified 5
(Date:8/22/2014)... (PRWEB) August 23, 2014 2014 ... is a professional and in-depth research report on ... Glucose Meter information, including Glucose Meter definition, classification, ... industry overview. This research covers the international market ... industry analysis covering macroeconomic environment & economic situation ...
(Date:8/22/2014)... Top 10 Best SEO Hosting (Top10BestSEOHosting.com) ... and highly recommended FatCow ( http://www.top10bestseohosting.com/go/FatCow.com/ ) and ... Top 10 Best SEO Hosting states, “It is ... supplier. Actually, these companies have outperformed their competitors ... support. People can get the best web hosting ...
(Date:8/22/2014)... With the stage set for the National ... - which will be held in Boston August 23-26 ... its online opinion section, Podium. The op-ed “ ... by Steven C. Anderson, IOM, CAE, president & CEO ... MCPHS University School of Pharmacy – Worcester/Manchester. , ...
(Date:8/22/2014)... Amy Norton HealthDay ... -- A growing number of Americans on work disability ... study. Researchers found that between 2007 and 2011, ... Insurance benefits were prescribed narcotic painkillers each year. And ... percent in 2007 to 23 percent in 2011. ...
(Date:8/22/2014)... 22, 2014 Millennium Treatment Group, ... Lantana, FL, recently launched a new website. Patients, ... information can now find Millennium Treatment Group at ... went live at the beginning of July. Everything ... can be found on the website. There’s an ...
Breaking Medicine News(10 mins):Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 2Health News:Glucose Meter Industry Global (Europe, Asia, NA, ROW) Analysis Now Available at ReportsnReports.com 3Health News:FatCow Reviews Released by Top10BestSEOHosting.com 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 2Health News:The Boston Globe Publishes Value of Pharmacy Op-ed as NACDS Total Store Expo Begins 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 2Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 3Health News:Many U.S. Workers on Disability Use Narcotic Painkillers, Study Finds 4Health News:Millennium Treatment Group Has a New Website 2
... Bears will visit hospitalized veterans on Veterans Day Tuesday,Nov. ... part of the Disabled,American Veterans (DAV) Celebrity Entertainment Program., ... Peterson are,scheduled to visit the hospital at 1:30 p.m., ... presenting patients with souvenirs and,helping brighten the day for ...
... to its hosting platform, new client acquisitions ... ... A series of successful initiatives,has driven Velocity Technology Solutions, Inc. ... management, hosting and,consulting services to the U.S. healthcare industry., ...
... in aftermath of earthquake, WASHINGTON, Nov. 10 ... the People,s Republic of China in providing,measles vaccines ... control activities and strengthening the delivery of routine,immunization ... Sichuan --,areas severely impacted by the 8.0 magnitude ...
... Grants support physical activity, nutrition, self-esteem and bullying ... ... The Highmark Foundation, through,the Highmark Healthy High 5 School Challenge ... and,bullying prevention programs in 130 Pennsylvania schools. The grants are,awarded ...
... NEW YORK, Nov. 10 The Neuropathy ... Scientific Research Grants,Program., Every year, The ... finding a cure for neuropathy--awards,two scientific research ... period., This year,s grant recipients--Gary J. ...
... Coordinated national planning needed to adapt to changing ... Without action by the,new Administration and Congress to ... U.S. is at risk of losing its status,as ... Association of Academic,Health Centers (AAHC). The Association calls ...
Cached Medicine News:Health News:Velocity Emerges as Healthcare Technology Leader 2Health News:Velocity Emerges as Healthcare Technology Leader 3Health News:Measles Initiative Supports Disease Prevention for Children in China's Earthquake Zone 2Health News:Measles Initiative Supports Disease Prevention for Children in China's Earthquake Zone 3Health News:Highmark Healthy High 5 School Challenge Grant Program Enables Pennsylvania Schools to Implement or Enhance Healthy Lifestyle Programs for Students 2Health News:Highmark Healthy High 5 School Challenge Grant Program Enables Pennsylvania Schools to Implement or Enhance Healthy Lifestyle Programs for Students 3Health News:Highmark Healthy High 5 School Challenge Grant Program Enables Pennsylvania Schools to Implement or Enhance Healthy Lifestyle Programs for Students 4Health News:Highmark Healthy High 5 School Challenge Grant Program Enables Pennsylvania Schools to Implement or Enhance Healthy Lifestyle Programs for Students 5Health News:Highmark Healthy High 5 School Challenge Grant Program Enables Pennsylvania Schools to Implement or Enhance Healthy Lifestyle Programs for Students 6Health News:Highmark Healthy High 5 School Challenge Grant Program Enables Pennsylvania Schools to Implement or Enhance Healthy Lifestyle Programs for Students 7Health News:The Neuropathy Association's Scientific Research Grants Focus: Autoimmune and Chemotherapy-Induced Neuropathies 2Health News:New Administration, Congress Must Act to Avert Health Workforce Crisis 2
... a minimum results in less emotional trauma ... the clinician. The innovative motor plus saw ... lighter package. In addition, the unique design ... more user comfort. Plus automated multi-speed controls ...
The True/Fix Cannulated Bone Screw System contains 7.0mm large cannulated bone screws and 3.5mm cortical and 4.0mm cannulated cancellous bone screws....
LEMAIRE stapes are stainless steel staples indicated for ligament fixation....
... Osteotomies and ligament ... a small number of ... Arthrodesis is the most ... of suitable staples allow ...
Medicine Products: